Diasorin various reagents and controls W/ use of liaison XL analyzer. Base period: 1 AUG 2023 - 30 SEP 2023
Active Purchase Order Awarded Last action
- Contract number
- W81K0223P0085
- Awardee
-
Diasorin Inc. UEI FGK2QR959BV5 Part of Diasorin S.P.A.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $228,227
Award facts
- Opportunity
-
- Various Reagents with use of Serology Analyzer Pre-Solicitation · W81K0223Q0061 · Posted Jun 2, 2023
- Contract value 68% obligated
- $334,751.26 Current and potential, with all options
- Completion date 78% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Stillwater, MN 55082, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$28,627 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $6,711 | |
| Funding Only Action | $99,817 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $99,817 | |
| Supplemental Agreement for work within scope | -$67,508 | |
| Exercise an Option | $0 | |
| Funding Only Action | $99,817 | |
| Exercise an Option | $0 | |
| Original award | $18,199 |
Show all 14
About this award
The Defense Health Agency awarded a purchase order to Diasorin Inc. on August 1, 2023, for various reagents and controls with use of the LIAISON XL analyzer, with a ceiling value of $334,751.26. The order was issued with no set-aside on a firm-fixed-price basis. Place of performance is Stillwater, Minnesota 55082. The base period runs August 1, 2023, through September 30, 2023, with ultimate completion on September 30, 2027. The requirement originated from a pre-solicitation notice posted June 2, 2023, by the Department of Pathology at Tripler Army Medical Center, Hawaii, seeking sources for reagents and instrumentation to run assays including QuantiFERON TB-Gold Plus and measles IgG on a serology analyzer. Responses were due June 9, 2023, under NAICS 325413.
Quick answers
Who was awarded contract W81K0223P0085?
W81K0223P0085 was awarded to Diasorin Inc. by Defense Health Agency (Department of Defense) on August 1, 2023.
How much is contract W81K0223P0085 worth?
The government has obligated $228,227 on W81K0223P0085. Its current value, with exercised options, is $334,751.
Was contract W81K0223P0085 competed?
The extent of competition for W81K0223P0085 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award